Table 1.

Population characteristics at the time of recruitment

Feature	All participants (N = 195)	Albendazole (N = 95)	Placebo (N = 100)	P value*
Age, median years (IQR)	40 (29–53)	39 (29–52)	43 (28–53)	0.6
Male gender, n (%)	67 (34)	26 (27)	41 (41)	0.05
Schooling, median years, (IQR)	6 (3–10)	6 (3–9)	6 (4–10)	0.4
Number of children in the household, median (IQR)	4 (2–7)	4 (2–7)	4 (2–7)	0.6
Anthropometry
Body mass index, median (IQR)	23 (21–25)	23 (21–25)	23 (22–25)	0.6
Percent body fat, median (IQR)	30 (22–36)	30 (20–36)	31 (26–36)	0.2
Living conditions
Earth floor, n (%)	118/191 (62)	65/93 (70)	53/98 (54)	0.07
River water source, n (%)	99/191 (52)	49/93 (53)	50/98 (51)	0.5
Lack of bathroom, n (%)	93/191 (49)	45/93 (48)	48/98 (49)	0.5
Socio-economics
Weekly money spent on food, median (IQR)	20 (10–40)	15 (10–35)	20 (10–50)	0.3
Food spending per day per person, median (IQR)†	0.14 (0.06–0.34)	0.12 (0.05–0.29)	0.12 (0.06–0.36)	0.2
Number of household residents, median (IQR)	6 (4–8)	6 (4–8)	6 (4–8)	0.9
Parasites history
Known past intestinal helminth infection, n (%)	145/183 (80)	69/90 (77)	76/93 (82)	0.4
Tuberculin skin test
Tuberculin skin-test size, median mm (IQR)	9 (5–16)	9 (5–16)	9 (5–16)	0.9
Tuberculin skin-test positivity (≥ 10 mm), n (%)	85/174 (49)	42/86 (49)	41/88 (47)	0.8
TB history
Known past TB disease, n (%)	12/192 (6)	5/94 (5)	7/98 (7)	0.8
Known past TB contact, n (%)	34/191 (18)	20/95 (21)	14/96 (15)	0.2
BCG
Absence of BCG scar, n (%)	33/188 (18)	18/92 (20)	15/96 (16)	0.5
One BCG scar, n (%)	64/188 (34)	34/92 (37)	30/96 (31)	0.4
Two or more BCG scar, n (%)	91/188 (48)	40/92 (43)	51/96 (53)	0.2

IQR = inter-quartile range; TB, tuberculosis.

^*Albendazole vs. placebo.

^†Money calculated in United States dollars.